Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities (Q37832409)

24 August 2017

1 reference

title

Implementing sentinel lymph node biopsy programs in developing countries: challenges and opportunities (English)

1 reference

24 August 2017

0 references

0 references

Mohammed Keshtgar

1

1 reference

24 August 2017

John J Zaknun

2

1 reference

24 August 2017

Durre Sabih

3

1 reference

24 August 2017

Graciela Lago

4

1 reference

24 August 2017

Charles E Cox

5

1 reference

24 August 2017

Stanley P L Leong

6

1 reference

24 August 2017

Giuliano Mariani

7

1 reference

24 August 2017

publication date

1 June 2011

1 reference

24 August 2017

published in

World Journal of Surgery

1 reference

24 August 2017

volume

35

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

1159-68; discussion 1155-8

1 reference

"Westernizing" women's risks? Breast cancer in lower-income countries

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

The rationale for sentinel-node biopsy in primary melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Axillary metastases in breast cancer patients with negative sentinel nodes: A follow-up of 3548 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

The revised American Joint Committee on Cancer staging system for melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Contraindications of sentinel lymph node biopsy: are there any really?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Implications of popliteal lymph node detected by sentinel lymph node biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Acral lentiginous melanoma: a clinicoprognostic study of 126 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Sentinel lymph node biopsy assessment using intraoperative imprint cytology in breast cancer patients: results of a validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Preclinical studies of [(99m)Tc]DTPA-mannosyl-dextran .

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Dose-dependent biodistribution of [(99m)Tc]DTPA-mannosyl-dextran for breast cancer sentinel lymph node mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

[(99m)Tc]MAG(3)-mannosyl-dextran: a receptor-binding radiopharmaceutical for sentinel node detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Randomized clinical trial comparing blue dye with combined dye and isotope for sentinel lymph node biopsy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Learning sentinel node biopsy: results of a prospective randomized trial of two techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Clinical role of sentinel-lymph-node biopsy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Molecular staging of the sentinel lymph node in melanoma patients: correlation with clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Prognostic significance of detecting micrometastases by tyrosinase RT/PCR in sentinel lymph node biopsies: lessons from 322 consecutive melanoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Correlation between molecular metastases in sentinel lymph nodes of breast cancer patients and St Gallen risk category

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Pathologic examination of the axillary sentinel lymph nodes in patients with early-stage breast carcinoma: current and resolving controversies on the basis of the European Institute of Oncology experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiothérapie Neoadjuvante, a French Prospective Multicentric Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00268-011-0956-3

Preoperative chemotherapy in operable breast cancer

21 January 2018

1 reference

12 December 2020

Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial.

1 reference

12 December 2020

The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures

1 reference

12 December 2020

Skin cancer in individuals of African, Asian, Latin-American, and American-Indian descent: differences in incidence, clinical presentation, and survival compared to Caucasians

1 reference

12 December 2020

Breast cancer incidence and determinants of cancer stage in the Western Cape.

1 reference

12 December 2020

Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence

1 reference

12 December 2020

Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection

1 reference

12 December 2020

The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI).

1 reference

12 December 2020

Breast cancer incidence in South Africa

1 reference

12 December 2020

Radiation safety of the sentinel lymph node technique in breast cancer

1 reference

12 December 2020

Intraoperative evaluation of sentinel lymph nodes for metastatic melanoma by imprint cytology

1 reference

12 December 2020

Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer

1 reference

12 December 2020

Low axillary sampling in clinically node-negative operable breast cancer

1 reference

12 December 2020

Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes

1 reference

12 December 2020

Intraoperative touch imprint cytology for the diagnosis of sentinel lymph node metastases in breast cancer

1 reference

12 December 2020

Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients

1 reference

12 December 2020

Acral lentiginous melanoma

1 reference

12 December 2020

Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.

1 reference

12 December 2020

Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial.

1 reference

12 December 2020

A synthetic macromolecule for sentinel node detection: (99m)Tc-DTPA-mannosyl-dextran.

1 reference

12 December 2020

10.1007/S00268-011-0956-3

Identifiers

DOI

1 reference

24 August 2017

1 reference